InvestorsHub Logo
Followers 52
Posts 9089
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Tuesday, 10/24/2023 11:44:20 AM

Tuesday, October 24, 2023 11:44:20 AM

Post# of 13461
the work continues_ Moderna, meanwhile, is working with Big Pharma Merck & Co., known as MSD here in Spain, on a personalized cancer vaccine called mRNA-4157 that is soon to enter phase 3. While the companies didn’t have major news to reveal at ESMO, both had a presence.
ESMO: Moderna, BioNTech's post-COVID futures in oncology hit manufacturing realities
https://www.fiercepharma.com/manufacturing/moderna-biontechs-post-covid-futures-oncology-hit-manufacturing-realities
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News